Swedish Orphan Biovitrum AB (publ) (STO:SOBI)

STO:SOBI Revenue

Swedish Orphan Biovitrum AB had revenue of 7.18B SEK in the quarter ending March 31, 2026, with 11.12% growth. This brings the company's revenue in the last twelve months to 28.96B, up 10.37% year-over-year. In the year 2025, Swedish Orphan Biovitrum AB had annual revenue of 28.24B with 8.50% growth.

• Revenue (ttm): 28.96B
• Revenue Growth: +10.37%
• P/S Ratio: 5.24
• Revenue / Employee: 14.71M
• Employees: 1,969
• Market Cap: 151.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	28.24B	2.21B	8.50%
Dec 31, 2024	26.03B	3.90B	17.65%
Dec 31, 2023	22.12B	3.33B	17.74%
Dec 31, 2022	18.79B	3.26B	21.00%
Dec 31, 2021	15.53B	268.00M	1.76%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error